{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:30:45Z","timestamp":1780410645576,"version":"3.54.1"},"reference-count":35,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T00:00:00Z","timestamp":1219795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>We sought to determine the association between body morphology abnormalities and depression, examining lipoatrophy and lipohypertrophy separately.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An observational cross\u2010sectional study of 250 patients from the University of Washington HIV Cohort was carried out. Patients completed an assessment including measures of depression and body morphology. We used linear regression analysis to examine the association between lipoatrophy or lipohypertrophy and depression. Analysis of variance was used to examine the relationship between mean depression scores and lipoatrophy and lipohypertrophy in 10 body regions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 250 patients, 76 had lipoatrophy and 128 had lipohypertrophy. Mean depression scores were highest among patients with moderate\u2010to\u2010severe lipoatrophy (16.4), intermediate among those with moderate\u2010to\u2010severe lipohypertrophy (11.7), mild lipohypertrophy (9.9) and mild lipoatrophy (8.5), and lowest among those without body morphology abnormalities (7.7) (<jats:italic>P<\/jats:italic>=0.002). After adjustment, mean depression scores for subjects reporting moderate\u2010to\u2010severe lipoatrophy were 9.2 points higher (<jats:italic>P<\/jats:italic>&lt;0.001), scores for subjects with moderate\u2010to\u2010severe lipohypertrophy were 4.8 points higher (<jats:italic>P<\/jats:italic>=0.02), and scores for subjects with mild lipohypertrophy were 2.8 points higher (<jats:italic>P<\/jats:italic>=0.03) than those for patients without body morphology abnormalities. Facial lipoatrophy was the body region associated with the most severe depression scores (15.5 <jats:italic>vs<\/jats:italic>. 8.9 for controls; <jats:italic>P=<\/jats:italic>0.03).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In addition to long\u2010term cardiovascular implications, body morphology has a more immediate effect on depression severity.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2008.00631.x","type":"journal-article","created":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T06:12:01Z","timestamp":1219817521000},"page":"780-786","source":"Crossref","is-referenced-by-count":32,"title":["Lipoatrophy among HIV\u2010infected patients is associated with higher levels of depression than lipohypertrophy"],"prefix":"10.1111","volume":"9","author":[{"given":"HM","family":"Crane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Grunfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RD","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KK","family":"Uldall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PS","family":"Ciechanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MM","family":"Kitahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"4845","article-title":"Clinical review 153","volume":"87","author":"Chen D","year":"2002","journal-title":"lipodystrophy in human immunodeficiency virus-infected patients"},{"key":"e_1_2_7_3_2","first-page":"2050","article-title":"Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy","volume":"160","author":"Tsiodras S","year":"2000","journal-title":"a 5-year cohort study"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200104130-00025"},{"key":"e_1_2_7_5_2","first-page":"714","article-title":"Health\u2010related quality of life in patients with human immunodeficiency virus infection in the United States","volume":"108","author":"Hays RD","year":"2000","journal-title":"results from the HIV cost and services utilization study"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.79.2.137"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-005-5001-2"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-004-2580-2"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2006.20.565"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000182230.47819.aa"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000229996.75116.da"},{"key":"e_1_2_7_12_2","first-page":"606","article-title":"The PHQ\u20109","volume":"16","author":"Kroenke K","year":"2001","journal-title":"validity of a brief depression severity measure"},{"key":"e_1_2_7_13_2","first-page":"1737","article-title":"Validation and utility of a self\u2010report version of PRIME\u2010MD","volume":"282","author":"Spitzer RL","year":"1999","journal-title":"the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire"},{"key":"e_1_2_7_14_2","first-page":"217","article-title":"Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)","volume":"24","author":"Newcombe DA","year":"2005","journal-title":"report of results from the Australian site"},{"key":"e_1_2_7_15_2","first-page":"1183","article-title":"The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)","volume":"97","author":"WHO ASSIST Working Group.","year":"2002","journal-title":"development, reliability and feasibility"},{"key":"e_1_2_7_16_2","unstructured":"GripshoverB TienPC SaagMS OsmondD BacchettiP GrunfeldC. Lipoatrophy is the dominant feature of the lipodystrophy syndrome in HIV\u2010infected men.10th Conference on Retroviruses and Opportunistic Infections Boston MA February2003[Abstract 732]."},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200312150-00003"},{"key":"e_1_2_7_18_2","first-page":"109","article-title":"Routine collection of patient\u2010reported outcomes in an HIV clinic setting","volume":"5","author":"Crane HM","year":"2007","journal-title":"the first 100 patients"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.8.721"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1659"},{"key":"e_1_2_7_21_2","unstructured":"National Institutes of Health.Appendix 6. Body Mass Index: how to measure obesity. Clinical guidelines on the identification evaluation and treatment of overweight and obesity in adults: the evidence report. NIH Publication #98\u20104083 pp.139\u2013140 1998."},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200412000-00006"},{"key":"e_1_2_7_23_2","first-page":"109","article-title":"Many faces of the minimal clinically important difference (MCID)","volume":"14","author":"Beaton DE","year":"2002","journal-title":"a literature review and directions for future research"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-006-9069-7"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.94.7.1133"},{"key":"e_1_2_7_26_2","first-page":"1466","article-title":"Mortality, CD4 cell count decline, and depressive symptoms among HIV\u2010 seropositive women","volume":"285","author":"Ickovics JR","year":"2001","journal-title":"longitudinal analysis from the HIV epidemiology research study"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.156.19.2233"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-1-200007040-00004"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-200107000-00021"},{"issue":"1","key":"e_1_2_7_30_2","first-page":"S49","article-title":"Psychiatric and neurocognitive disorders among HIV\u2010positive and negative veterans in care","volume":"18","author":"Justice AC","year":"2004","journal-title":"Veterans Aging Cohort Five-Site Study"},{"key":"e_1_2_7_31_2","first-page":"61","article-title":"Measuring depression outcome with a brief self\u2010report instrument","volume":"81","author":"Lowe B","year":"2004","journal-title":"sensitivity to change of the Patient Health Questionnaire (PHQ-9)"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.47.1.62"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2005.07.003"},{"key":"e_1_2_7_34_2","first-page":"759","article-title":"Validity and utility of the PRIME\u2010MD patient health questionnaire in assessment of 3000 obstetric\u2010gynecologic patients","volume":"183","author":"Spitzer RL","year":"2000","journal-title":"the PRIME-MD patient health questionnaire obstetrics-gynecology study"},{"key":"e_1_2_7_35_2","first-page":"p. xxvii","volume-title":"Task Force on DSM\u2010IV. Diagnostic and Statistical Manual of Mental Disorders: DSM\u2010IV","author":"American Psychiatric Association.","year":"1994"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2006.00342.x"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2008.00631.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2008.00631.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T21:10:35Z","timestamp":1696885835000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2008.00631.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1111\/j.1468-1293.2008.00631.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2008.00631.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}